IP Library Granted Patent US 9,816,986
Granted Patent B2
US 9,816,986 · App. 15/440,408 · Granted Nov 14, 2017

Detection of 5-hydroxymethylcytosine by glycosylation

Inventors: Anjana Rao (La Jolla, CA); Mamta Tahiliani (New York, NY); Kian Peng Koh (Jamaica Plain, MA); Suneet Agarwal (Belmont, MA); Aravind Iyer (Bethesda, MD)
Assignee: Children's Medical Center Corporation
G01N33/5308C12N5/0696G01N33/57496C12N2501/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,816,986
App. No.
15/440,408
Granted
Nov 14, 2017
Kind
B2
Abstract

Provided herein are methods and kits for detecting a modified cytosine.

Claims (11)

1. A method for detecting 5-hydroxymethylcytosine in a mammalian nucleic acid, the method comprising:

contacting a sample comprising said mammalian nucleic acid with an enzyme that utilizes a labeled glucose or a labeled glucose-derivative donor substrate to add a labeled glucose molecule or a labeled glucose-derivative to a 5-hydroxymethylcytosine nucleic acid residue to generate a labeled glucosylated-5-hydroxymethylcytosine,

wherein the enzyme is a beta-glucosyltransferase and

wherein the labeled glucose or the labeled glucose-derivative donor substrate comprises a uridine diphosphate glucose (UDPG); and treating the contacted sample with a TET enzyme or a catalytically active fragment thereof comprising SEQ ID NO: 1.

2. The method of claim 1 , wherein the labeled glucose or the labeled glucose-derivative donor substrate is radioactively labeled.

3. The method of claim 1 , wherein the beta-glucosyltransferase comprises an Asp-Ile-Arg-Leu sequence.

4. The method of claim 1 , wherein the beta-glucosyltransferase is encoded by a T4 bacteriophage.

5. The method of claim 1 , wherein the mammalian nucleic acid comprises mammalian DNA.

6. The method of claim 1 , further comprising conducting a nucleic acid sequencing.

7. The method of claim 1 , wherein the mammalian nucleic acid comprises a 5-methylcytosine.

8. The method of claim 7 , further comprising distinguishing a 5-hydroxymethylcytosine from the 5-methylcytosine.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2017
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 043585/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2017
From: RAO, ANJANA; TAHILIANI, MAMTA; KOH, KIAN PENG
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 043506/0504 →
MERGER Recorded Sep 6, 2017
From: IMMUNE DISEASE INSTITUTE, INC.
To: THE CHILDREN'S HOSPITAL CORPORATION
Reel/Frame 043506/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2017
From: THE CHILDREN'S HOSPITAL CORPORATION
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 043506/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2017
From: AGARWAL, SUNEET
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 043506/0539 →
Continuity (8)
Continuation 15341344 · Nov 2, 2016
Continuation 15193796 · Jun 27, 2016
Continuation 13795739 · Mar 12, 2013
Continuation 13120861
Provisional Application 61100503 · Sep 26, 2008
Provisional Application 61100995 · Sep 29, 2008
Provisional Application 61121844 · Dec 11, 2008
Related Publication 20170176421A1 · Jun 22, 2017